India Cements has seen a reco and target upgrade in the build up to its results. Rising cement prices have buoyed up the cement industry in general, and India Cements is one of the stocks that successfully doubled investor value in the past year. Strong infra growth predictions for the coming six months, and higher rural incomes boosting spending on construction, is likely to keep this stock on the up. 

Axis Bank is on a sharp upswing, landing both reco and target upgrades. Axis has been aggressively pursuing new markets, and has been able to outpace industry growth, delivering 19% CAGR so far in its loan book. The bank also tied up in August with Suvidhaa to provide 'nano credit' to the highly underserved rural credit market, and is following ICICI Bank in piloting blockchain transactions. 

Jamna Auto's impressive Q1 performance after two uninspired quarters has stoked interest and optimism in the company, and its seen both its recommendation and target upped. The company will benefit from the boost in the auto sector and freight this season - increased agriculture output has boosted truck demand, and the company is the dominant supplier of leaf and parabolic springs for the commercial vehicle market. 

Alkem Labs is currently trading above its 150 day SMA, but the company stock was downgraded recently to 'Neutral'. The company ran afoul with the US regulator, the FDA, whose inspection of its Daman plant has found 13 violations. The Daman facility accounts for 30% of the company's FY '16 US revenues (6% of total revenues). Addressing the FDA objections will be key to the company getting an important approval certification in November.  

BPCL has seen a recent 'hold' call for its stock. The stock is trading at a year high as well as above its 30 day SMA. BPCL has aggressive refinery expansion plans, including in the northeast to take advantage of Central government tax incentives to invest in the region.